Blue Owl Capital Corporation Common Stock OBDC 深 沪
已收盘 12-19 16:00:00 美东时间
12.65
-0.050
-0.39%
华盛通- 最 高12.72
- 今 开12.69
- 成交量 663.09万股
- 最 低 12.57
- 昨 收 12.70
- 总市值 64.64亿
- 52周最高 14.795
- 市盈率 静 8.29
- 换手率 0.00%
- 52周最低 11.34
- 委 比 -89.92%
- 总股本 5.11亿
- 历史最高 14.54
- 量 比 1.59
- 振 幅 1.18%
- 历史最低 -0.50
- 每 手 1
- 风险率 0.62%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股12月收息策略：最高股息率超11%！泰森食品、惠普、英美烟草等超100家高分红股如何布局！
最高股息率超11%！泰森食品、惠普、英美烟草等超100家高分红股如何布局！投资者可在除息前布局，赚取股息！一文速览派息名单>>
12-01 14:00
Alpha Buying: Insurers Warn. Credit Tightens. Insiders Buy Anyway.
If you spend any time in the Business Development Company (BDC) world right now...
11-27 00:20
Blue Owl Capital, Blue Owl Capital Corp. II Announce Merger Termination
Blue Owl Capital Corporation (NYSE:OBDC) ("OBDC") and Blue Owl Capital Corporation II ("OBDC II") today announced that the previously proposed merger of OBDC and OBDC II has been terminated, with plans to reevaluate
11-19 22:12
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
11-11 10:49
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 10:22
Blue Owl Capital Q3 Adj. EPS $0.36 Misses $0.40 Estimate, Sales $446.307M Miss $467.190M Estimate
Blue Owl Capital (NYSE:OBDC) reported quarterly earnings of $0.36 per share which missed the analyst consensus estimate of $0.40 by 9.09 percent. This is a 2.86 percent increase over earnings of $0.35 per share from the
11-06 07:08
Blue Owl Capital, Blue Owl Capital Corporation I Sign Merger Agreement
Blue Owl Capital Corporation (NYSE: OBDC) ("OBDC") and Blue Owl Capital Corporation II ("OBDC II") announced today that they have entered into a definitive merger agreement, with OBDC as the surviving company,
11-06 05:38
Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
